Navigating Weight Loss: Can You Take Ozempic with Topiramate?

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people exploring weight loss treatment wonder whether they can safely combine semaglutide (Ozempic) with topiramate, an anticonvulsant medication sometimes prescribed off-label for weight management. Both medications work through different biological pathways, making the question of compatibility an important one for anyone considering dual therapy. Understanding how these drugs interact and whether they work well together requires looking at clinical evidence and individual health factors.

How Semaglutide and Topiramate Work Differently in Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that slows stomach emptying, increases feelings of fullness, and reduces appetite through signals in the brain. It works on specific receptors in the hypothalamus and other areas that regulate hunger hormones like ghrelin and peptide YY. Clinical trials show semaglutide can produce 10-15% body weight reduction over 68 weeks in people with obesity.

Topiramate functions as a carbonic anhydrase inhibitor with unclear exact mechanisms for weight loss, though it may enhance satiety and reduce cravings through effects on GABA pathways. It does not directly target GLP-1 receptors like semaglutide does. Topiramate typically produces 5-9% weight loss when used as monotherapy, making it a less potent option than modern GLP-1 medications.

Potential Drug Interactions Between Ozempic and Topiramate

Direct pharmacokinetic interactions between semaglutide and topiramate are minimal, as they metabolize through different pathways and do not compete for the same liver enzymes. Semaglutide undergoes proteolytic degradation, while topiramate relies on renal clearance, meaning they do not interfere with each other's absorption or elimination at the molecular level. Most medical literature suggests no significant contraindication to using both medications together.

However, additive effects on appetite suppression and gastrointestinal function should be considered. Both medications can cause nausea, vomiting, or changes in appetite, and combining them may amplify these side effects, particularly when beginning treatment. Additionally, topiramate can increase the risk of kidney stone formation and affect electrolyte balance, which may be compounded by dehydration from GLP-1 side effects or reduced oral intake.

Safety Considerations and Medical Supervision Requirements

Before combining semaglutide with topiramate, a thorough medical evaluation is necessary to assess kidney function, electrolyte levels, and personal risk factors for dehydration. People with a history of pancreatitis, medullary thyroid cancer, or multiple endocrine neoplasia syndrome 2 should avoid semaglutide regardless of whether topiramate is present. Those taking topiramate should already be monitored for cognitive changes, bone density loss, and metabolic acidosis—factors that may worsen with reduced caloric intake.

Dosing adjustments may be needed if either medication has previously caused side effects. Starting semaglutide at the lowest dose (0.25 mg weekly) while maintaining stable topiramate dosing allows safer assessment of combined tolerability. Regular follow-up visits with a prescribing physician are essential to monitor weight loss progress, side effect burden, and whether both medications remain medically appropriate.

Is Combined Therapy Right for You? Personalized Weight Loss Planning

The decision to use both medications should be based on individual health history, treatment goals, and prior response to each drug separately. People who have not achieved adequate weight loss with topiramate alone may benefit from adding semaglutide, though newer GLP-1 options like tirzepatide offer dual-receptor activation and potentially greater efficacy. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies, providing access to personalized GLP-1 therapy without insurance requirements.

PlexusDx also offers the Precision Peptide Genetic Test ($298) that maps 14 pathways and 49 peptides to identify genetic variations in GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) that influence weight loss response. This genetic insight helps determine whether semaglutide, tirzepatide, or a dual-compound approach will work best for your specific biology, removing guesswork from medication selection and supporting truly personalized treatment decisions.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Can I take Ozempic and topiramate at the same time?

Yes, there are no direct drug interactions between semaglutide and topiramate, as they metabolize through different pathways. However, combining them may increase side effects like nausea and dehydration, so medical supervision is essential. A prescribing physician should monitor kidney function and electrolytes before and during combined therapy.

Does combining these medications cause better weight loss than using just one?

Combining semaglutide with topiramate may produce additive weight loss effects due to their different mechanisms, though clinical evidence specifically comparing dual therapy is limited. Semaglutide alone achieves 10-15% weight loss, while topiramate adds roughly 5-9%, suggesting potential for greater total loss when used together—but individual results vary significantly.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement, no membership fee, and HSA/FSA eligibility. Your dose may need to go up as treatment progresses, but your price won't change.

What side effects should I watch for when combining these drugs?

Watch for increased nausea, vomiting, appetite loss, fatigue, and signs of dehydration such as dark urine or dizziness. Topiramate-specific concerns include cognitive fogginess, tingling sensations, and kidney stone symptoms (sudden flank pain). Report any new or worsening symptoms to your prescribing provider immediately.

How can PlexusDx genetic testing help me choose between semaglutide and other GLP-1 options?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.